The Aging Brain Initiative is a multi-dimensional collaborative effort that integrates research from the fields of neuroscience, genetics, computer science, urban planning, systems engineering, and finance.

The Aging Brain Initiative at MIT sits uniquely positioned to develop treatments and technologies for Alzheimer’s disease and dementia as MIT is ranked first in science and engineering, drug development and innovation, and it sits at the epicenter of the largest concentration of biotechnology companies and research centers in the world.

MIT is the predominate model for technology transfer and given the institutions proven history of innovative solutions to the worlds toughest problems the Aging Brain Initiative is confident that it can create the first generation of therapies that treat and offset the progression of Alzheimer’s disease and dementia.